BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, June 5, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 12, 2018
View Archived Issues
Evotec and Petra Pharma to apply the INDiGO platform and accelerate Petra-01 development
Read More
First patient treated in phase Ib/II study of tractinostat in EBV+ lymphoma
Read More
FIMECS, Takeda enter license agreement to develop novel immuno-oncology therapies
Read More
Zealand, Roche Diabetes Care collaborate in phase III trial of dasiglucagon for CHI
Read More
United Neuroscience announces collaboration to evaluate vaccine candidates for Alzheimer's
Read More
miR-31 and miR-3150b predict EGFR TKI efficacy in squamous cell lung carcinoma
Read More
Veracyte enters collaboration with Loxo Oncology to advance oncology precision medicine
Read More
CNTO-3157 fails to attenuate rhinovirus-induced experimental asthma exacerbations
Read More
Treos Bio activates U.S. site in phase I trial of PolyPEPI-1018
Read More
Novel LDLR-PCSK9 protein-protein interaction inhibitors discovered at Texas A&M University
Read More
FDA lifts clinical hold on BPX-501 in U.S.
Read More
Assembly Biosciences presents new hepatitis B core protein modulators
Read More
Jiangsu Chia Tai Tianqing Pharmaceutical Group describes HBV capsid assembly inhibitors
Read More
Reata offers update on ongoing CARDINAL study of bardoxolone in Alport syndrome
Read More
Entasis Therapeutics patents new beta-lactamase inhibitors
Read More
CNRS, Universite d'Orleans identify novel agents for filovirus infections
Read More
Fujifilm Kyowa Kirin Biologics licenses rights to Mylan to commercialize adalimumab biosimilar
Read More
Destiny's discussions with FDA clarify overall clinical trial plans for XF-73
Read More
University of Oxford initiates phase I trial of MERS-CoV vaccine
Read More
Pfizer initiates comparative phase III study of aztreonam/avibactam in Gram-negative infections
Read More
Arbutus Biopharma and Roivant Sciences launch jointly owned Genevant Sciences
Read More
Mutation in FPN1 gene found to protect against malaria infection
Read More
